Andreas Wicki

Tumor invasion in the absence of epithelial-mesenchymal transition: Podoplanin-mediated remodeling of the actin cytoskeleton

Andreas Wicki, François Lehembre, Nikolaus Wick et al. · Cancer Cell · 2006 · 582 citations · Full text

Life Sciences, Cell Biology, Oncology +17

Tolerability, safety, pharmacokinetics, and efficacy of doxorubicin-loaded anti-EGFR immunoliposomes in advanced solid tumours: a phase 1 dose-escalation study

Christoph Mamot, Reto Ritschard, Andreas Wicki et al. · The Lancet Oncology · 2012 · 238 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Systemic inflammation in a melanoma patient treated with immune checkpoint inhibitors—an autopsy study

Viktor H. Koelzer, Sacha I. Rothschild, Deborah Zihler et al. · Journal for ImmunoTherapy of Cancer · 2016 · 200 citations · Full text

Medicine, Oncology, Pathology +17

NCAM‐induced focal adhesion assembly: a functional switch upon loss of E‐cadherin

François Lehembre, M. Deniz Yilmaz, Andreas Wicki et al. · The EMBO Journal · 2008 · 185 citations · Full text

Life Sciences, Cell Biology, Cell Adhesion +13

[Lys40(Ahx-DTPA-111In)NH2]exendin-4, a very promising ligand for glucagon-like peptide-1 (GLP-1) receptor targeting.

Damian Wild, Martin Béhé, Andreas Wicki et al. · PubMed · 2006 · 171 citations

Medicine, Oncology, Pharmacology +17